NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 1 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $26,000 | +160.0% | 186,972 | +94.1% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -60.0% | 96,325 | -10.0% | 0.00% | -50.0% |
| Q3 2018 | $25,000 | +177.8% | 107,033 | +169.7% | 0.00% | – |
| Q2 2018 | $9,000 | +125.0% | 39,683 | +260.3% | 0.00% | – |
| Q1 2018 | $4,000 | -33.3% | 11,014 | -32.7% | 0.00% | – |
| Q4 2017 | $6,000 | +50.0% | 16,355 | +53.9% | 0.00% | – |
| Q3 2017 | $4,000 | – | 10,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |